Lunit to showcase Lunit SCOPE capabilities at ASCO Annual Meeting
– New studies reveal Lunit SCOPE’s impact on predicting clinical outcomes, analyzing tumor microenvironment, and enhancing personalized cancer treatment Lunit (KRX:328130.KQ), a global leader of...